NMRAVSSLS• Today (Normalized)
NMRA vs SLS (Neumora Therapeutics Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep, 10 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NMRA Performance $1.04
-8.77%
Neumora Therapeutics Inc.
Normalized Baseline0.00%
SLS Performance $11.55
-14.38%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin NMRA LEADS
+5.61%
NMRA outperforming by 5.61%
NMRASLS
Spread TrajectoryToday (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NMRA SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(2 dates)
| Date | NMRA Price | NMRA Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.04 | -8.77% | $11.55 | -14.38% | +5.61% |
| Sep 10, 2026 | $1.14 | +0.00% | $13.49 | +0.00% | +0.00% |